BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15718112)

  • 1. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
    Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
    J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
    Baujat B; Mahé C; Pignon JP; Hill C
    Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical methodology of meta-analysis of individual patient data using a survival outcome.
    Katsahian S; Latouche A; Mary JY; Chevret S; Porcher R
    Contemp Clin Trials; 2008 Mar; 29(2):220-30. PubMed ID: 17884735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
    Smith CT; Williamson PR; Marson AG
    Stat Med; 2005 May; 24(9):1307-19. PubMed ID: 15685717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.
    Schmid CH; Stark PC; Berlin JA; Landais P; Lau J
    J Clin Epidemiol; 2004 Jul; 57(7):683-97. PubMed ID: 15358396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
    Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
    Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
    Kollar C; Schneider H; Waksman J; Krusinska E
    Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.
    Pignon JP; le Maître A; Bourhis J;
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S112-4. PubMed ID: 17848275
    [No Abstract]   [Full Text] [Related]  

  • 18. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.
    Teramukai S; Matsuyama Y; Mizuno S; Sakamoto J
    Jpn J Clin Oncol; 2004 Dec; 34(12):717-21. PubMed ID: 15640501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analyses of randomized trials in oncology: pros and cons].
    Hill C; Pignon JP
    Bull Cancer; 1999 Mar; 86(3):259-64. PubMed ID: 10210759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.